Detalhe da pesquisa
1.
Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation.
Immunity
; 53(1): 98-105.e5, 2020 07 14.
Artigo
Inglês
| MEDLINE | ID: mdl-32561270
2.
Human immunoglobulin gene allelic variation impacts germline-targeting vaccine priming.
NPJ Vaccines
; 9(1): 58, 2024 Mar 11.
Artigo
Inglês
| MEDLINE | ID: mdl-38467663
3.
A first-in-human germline-targeting HIV nanoparticle vaccine induced broad and publicly targeted helper T cell responses.
Sci Transl Med
; 15(697): eadf3309, 2023 05 24.
Artigo
Inglês
| MEDLINE | ID: mdl-37224227
4.
Human immunoglobulin gene allelic variation impacts germline-targeting vaccine priming.
medRxiv
; 2023 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-36993183
5.
Vaccination induces HIV broadly neutralizing antibody precursors in humans.
Science
; 378(6623): eadd6502, 2022 12 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36454825
6.
Generation of a cost-effective cell line for support of high-throughput isolation of primary human B cells and monoclonal neutralizing antibodies.
J Immunol Methods
; 488: 112901, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33069767
7.
Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects.
Cell Rep
; 36(2): 109353, 2021 07 13.
Artigo
Inglês
| MEDLINE | ID: mdl-34237283
8.
Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects.
bioRxiv
; 2021 Mar 24.
Artigo
Inglês
| MEDLINE | ID: mdl-33791692